Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
Saved in:
Chen, L.S., ET AL., Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). Addiction, Vol. 109, no. 1 (2014), p. 128-139.
Ref.
196549
Location:
SIIS R.696 Archivo
Palabras clave:
Drogodependencias, Efectos, Fármacos, Genética, Nicotina de sustitución, Programas de mantenimiento, Reducción de daños, Resultados, Tabaquismo, Tratamiento médico
Drogodependencias, Efectos, Fármacos, Genética, Nicotina de sustitución, Programas de mantenimiento, Reducción de daños, Resultados, Tabaquismo, Tratamiento médico
Similar Items: Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
- Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
- ASSOCIATION OF CYP2D6 ULTRARAPID METABOLIZER GENOTYPE WITH DEFICIENT PATIENT SATISFACTION REGARDING METHADONE MAINTENANCE TRATMENT
- VARYING NICOTINE PATCH DOSE AND TYPE OF SMOKING CESSATION COUNSELING
- Changes in the rate of nicotine metabolism across pregnancy: a longitudinal study
- Systematic review and meta-analysis investigating nicotine,cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy
- PHARMACOTHERAPIES TO ENHANCE SMOKING CESSATION DURING PREGNANCY